Liver tissue microenvironment

“Liver tissue microenvironment” describes the dynamic and heterogeneous assemblage of cellular (immune cells, hepatocytes, endothelial cells, fibroblasts/Kupffer cells) and non-cellular (extracellular matrix proteins, cytokines, growth factors) components within liver tissue. This microenvironment maintains normal liver homeostasis but, in disease (notably cancer), undergoes remodeling that supports tumor initiation, progression, metastasis, and therapy resistance. The biology of this context is defined by complex cell-cell and cell-matrix interactions, immune cell infiltration and polarization, and changes in signaling molecules. It is a key determinant of pathological progression in liver disorders and a subject of many therapeutic strategies, but is not a single molecular “target” like a receptor or enzyme. This entry should be considered not a canonical single target, but a biological context with substantial molecular complexity.

Other names

liver microenvironmenthepatic microenvironmentliver tumor microenvironmentTME (when context is cancer)

Modulation of immune response: enhancing T cell infiltration or reducing immune suppression; Inhibition of angiogenesis: targeting endothelial cells/VEGF pathway; ECM remodeling: breaking down fibrosis/scar tissue to alter cell migration or drug accessibility; Alteration of cell-cell signaling: disrupting communication between malignant, stromal, and immune cells.